Evidence map›Paper›PMID 37253877›Full record

ReviewNature reviews. Immunology2023

Localization, tissue biology and T cell state - implications for cancer immunotherapy.

Jason M Schenkel, Kristen E Pauken

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
28.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Therapeutic efficacy and oncological prognosis of ypTNM 0-I gastric cancer after neoadjuvant therapy: a multicenter propensity-score matched study in China.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  11. HBV-driven expansion of CXCR6Innovation (Cambridge (Mass.)) · 2026
    Article
  12. Article
  13. Article
  14. Covalent tumor anchoring spatially orchestrates antitumor immunity.bioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jason M SchenkelDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jmschenkel@mdanderson.org.ORCID 0000-0003-4641-6872
Kristen E PaukenDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kepauken@mdanderson.org.ORCID 0000-0002-4309-7880
The University of Texas MD Anderson Cancer Center · US

Funding

The ontogeny and function of CD8 T cells in lung cancerK08CA256044 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHENKEL, JASON M. · 2021 to 2025
$1.1M
NCI NIH HHS K08 CA256044
6 · The paper itself

Abstract

Tissue localization is a critical determinant of T cell immunity. CD8

Indexed as

CD8-Positive T-LymphocytesNeoplasmsBiologyHumansImmunologic MemoryImmunotherapyTumor Microenvironment

Identifiers

PMID37253877
PMCPMC11448857
OpenAlexW4378783001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.